Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs

Swiss Medical Weekly

Volumn 136, Issue 43-44, 2006, Pages 684-690

  Roll, Antonie ^a   Wüthrich, Brunello ^a   Schmid Grendelmeier, Peter ^a   Hofbauer, Günther ^a   Ballmer Weber, Barbara K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Celecoxib; Hypersensitivity; Intolerance; Nonsteroidal anti inflammatory drugs (NSAIDs); Oral challenge; Tolerance

Indexed keywords

ACETMETACIN; ACETYLSALICYLIC ACID; ACRIVASTINE; CELECOXIB; CLONIXIDIN; DICLOFENAC; DIPYRONE; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOBARBITAL; PIROXICAM; PREDNISOLONE; PROPYPHENAZONE; PYRAZOLONE; QUININE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; DYSPNEA; FEMALE; FLUSHING; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; PROVOCATION TEST; PRURITUS; RHINITIS; RHINOCONJUNCTIVITIS; SIDE EFFECT; SKIN MANIFESTATION; SKIN TEST; SYMPTOM; URTICARIA; VOMITING;

EID: 33845576847     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum. 1996;39:713-22.
2. Schnitzer TJ, Truitt K, Fleischmann R, Dalgin P, Block J, Zeng Q, et al. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. Clin Ther. 1999; 21:1688-702.
3. Christie PE, Smith C, Arm JP, Lee TH. Aspirin sensitive asthma. Clin Exp Allergy. 1992;22:171-5.
4. Slepian IK, Mathews KP, McLean JA. Aspirin-sensitive asthma. Chest. 1985;87:386-91.
5. Yates AB, deShazo RD. Allergic and nonallergic drug reactions. South Med J 2003;96:1080-7.
6. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol. 1999;48:839-i6.
7. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;89:542-50; quiz 550, 605.
8. Settipane GA. Aspirin sensitivity and allergy. Biomed Pharmacother. 1988;42:493-8.
9. Zeitz HJ. Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome. Clin Chest Med. 1988;9:567-76.
10. Falliers CJ. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol. 1973;52:141-7.
11. Sanchez-Borges M, Capriles-Hulett A. Atopy and NSAID sensitivity. J Allergy Clin Immunol. 1997;100:143-4.
12. Sanchez-Borges M, Capriles-Hulect A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000;84:101-6.
13. Hoigne R, Schlumberger HP, Vervloet D, Zoppi M. Epidemiology of allergic drug reactions. Monogr Allergy. 1993;31: 147-70.
14. Motilva V, Alarcon de la Lastra C, Bruseghini L, Manuel Herrerias J, Sanchez-Fidalgo S. COX expression and PGE(2) and PGD(2) production in experimental acute and chronic gastric lesions. Int Immunopharmacol 2005;5:369-79.
15. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 1991;88:2692-6.
16. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
17. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, et al. Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 2002; 121:1812-7.
18. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834-46.
19. Bernstein IL, Storms WW. Practice parameters for allergy diagnostic testing. Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma. The American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1995;75:543-625.
20. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-80.
21. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Update on sensitivity to nonsteroidal antiinflammatory drugs. Curr Drug Targets Immune Endocr Metabol Disord 2001;1:233-40.
22. Senna G, Bilo MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P, et al. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Allerg Immunol (Paris) 2004;36: 215-8.
23. Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy 2002;32:397-400.
24. Liccardi G, D'Amato G, Canonica GW, Lobefalo G, Noschese P, Piccolo A, et al. Safety of celecoxib in patients with adverse reactions to nimesulide. Allergy 2005;60:708-9.
25. Quiralte J, Delgado J, Saenz de San Pedro B, Lopez-Pascual E, Nieto MA, Ortega N, et al. Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2004;93:360-4.
26. Sanchez Borges M C-HA, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001; 87:201-4.
27. Schuster C, Wuthrich B. Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross reactivity or coincidence? Allergy 2003;58:1072.
28. Grob M, Pichler WJ, Wuthrich B. Anaphylaxis to celecoxib. Allergy 2002;57:264-5.
29. Fontaine C, Bousquet PJ, Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005;115:633-4.
30. Gagnon R, Julien M, Gold P. Selective celecoxib-associated anaphylactoid reaction. J Allergy Clin Immunol 2003;111:1404-5.
31. Levy MB, Fink JN. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001;87:72-3.
32. Perna AG, Woodruff CA, Markus RF, Hsu S. Toxic epidermal necrolysis as a complication of treatment with celecoxib. Dermatol Online J 2003;9:25.
33. Goeschke B, Braathen LR. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology 2004;209:53-6.
34. Grob M, Scheidegger P, Wuthrich B. Allergic skin reaction to celecoxib. Dermatology 2000;201:383.
35. Szczeklik A. Analgesics, allergy and asthma. Drugs. 1986;32 (Suppl 4):148-63.
36. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434.
37. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol. 1989;84:26-33.
38. Szczeklik A. Aspirin-induced asthma: new insights into pathogenesis and clinical presentation of drug intolerance. Int Arch Allergy Appl Immunol. 1989;90(Suppl 1):70-5.
39. Barles PG, Duce Garcia F, Portillo Olmo JR, Perez Aznar J, Escuer Alarma JL. Adverse reaction of acetaminophen as an alternative analgesic in A.A.S. Triad. Allergol Immunopathol (Madr). 1988;16:321-5.
40. Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs. 1993; 46(Suppl 1):253-6.
41. Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy. 1994;72:29-32.
42. Bavbek S, Celik G, Ediger D, Mungan D, Demirel YS, Misirligil Z. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma. 1999;36:657-63.
43. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Investig Allergol Clin Immunol 2003;13:20-5.
44. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy. 1998;53: 1231-3.
45. Bianco S, Robuschi M, Petrigni G, Scuri M, Pieroni MG, Refini RM, et al. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs. 1993;46(Suppl 1): 115-20.
46. Weiss P, Mouallem M, Bruck R, Hassin D, Tanay A, Brickman CM, et al. Nimesulide-induced hepatitis and acute liver failure. Isr Med Assoc J. 1999;1:89-91.